Opinion

Video

Targeting Disease Modification in Psoriasis and Psoriatic Arthritis

Dermatologic experts explore strategies to slow the progression of psoriasis to psoriatic arthritis, offering evidence-based insights to optimize patient outcomes and enhance long-term disease management.

0:00 Overlap of PsO and PsA
4:00 Detecting Early PsA
13:20 Treatments for PsA
18:00 Defining Minimal Disease Activity
24:50 Biologics for PsA
31:00 Efficacy of IL-17i and IL-23i
37:00 Preventing Progression from PsO to PsA

Related Videos
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Melodie Young, ASN, RN: Updates on Therapies for Pediatric Patients with Psoriasis, PsA
Harnessing Patient Insights: The Role of PROs in Managing Psoriasis and Psoriatic Arthritis
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
© 2024 MJH Life Sciences

All rights reserved.